Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,500 | 1 | 49.2% |
| Food and Beverage | $1,905 | 50 | 37.5% |
| Travel and Lodging | $597.16 | 3 | 11.7% |
| Education | $81.12 | 4 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $3,401 | 14 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $583.65 | 13 | $0 (2024) |
| Alimera Sciences, Inc. | $319.45 | 6 | $0 (2022) |
| Genentech USA, Inc. | $218.14 | 6 | $0 (2024) |
| ABBVIE INC. | $196.93 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $175.51 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $63.72 | 5 | $0 (2019) |
| Harrow Eye, LLC | $32.14 | 1 | $0 (2024) |
| Boston Scientific Corporation | $29.16 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $27.22 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $365.68 | 13 | Regeneron Healthcare Solutions, Inc. ($217.49) |
| 2023 | $290.68 | 6 | Astellas Pharma US Inc ($122.49) |
| 2022 | $272.56 | 8 | Alimera Sciences, Inc. ($174.77) |
| 2021 | $110.43 | 1 | AbbVie Inc. ($110.43) |
| 2020 | $125.25 | 3 | Regeneron Healthcare Solutions, Inc. ($90.79) |
| 2019 | $220.93 | 8 | Alimera Sciences, Inc. ($144.68) |
| 2018 | $221.23 | 6 | Regeneron Healthcare Solutions, Inc. ($107.82) |
| 2017 | $3,477 | 13 | Allergan Inc. ($3,372) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Harrow Eye, LLC | IHEEZO (Drug), TRIESENCE | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: OPTOMETRY | ||||||
| 10/10/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Ophthalmology | ||||||
| 10/01/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: EYE CARE | ||||||
| 08/09/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: EYE CARE | ||||||
| 07/25/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $20.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $20.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $19.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $19.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $1.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/08/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $109.36 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/04/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: Ophthalmology | ||||||
| 12/15/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/14/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/13/2023 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $122.49 | General |
| Category: Ophthalmology | ||||||
| 12/05/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: EYE CARE | ||||||
| 10/25/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $94.46 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/13/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/14/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/10/2022 | Boston Scientific Corporation | ZOOM Wireless Transmitter (Device) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: ZOOM_CRM | ||||||
| 11/10/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $17.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/19/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $78.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/19/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $78.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/21/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 4,889 | 49,544 | $9.2M | $3.8M |
| 2022 | 27 | 5,080 | 19,202 | $7.8M | $3.3M |
| 2021 | 28 | 4,783 | 14,206 | $7.4M | $3.2M |
| 2020 | 24 | 4,567 | 12,617 | $6.4M | $2.7M |
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 334 | 3,184 | $4.8M | $2.2M | 45.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 100 | 35,100 | $2.1M | $1.0M | 48.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 443 | 2,335 | $823,410 | $195,038 | 23.7% |
| 92134 | Imaging of retina | Office | 2023 | 1,025 | 3,394 | $339,400 | $98,135 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 402 | 963 | $178,155 | $62,013 | 34.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 512 | 676 | $125,060 | $56,584 | 45.2% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 11 | 240 | $48,000 | $28,887 | 60.2% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 17 | 182 | $69,160 | $28,856 | 41.7% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 998 | 2,260 | $180,800 | $25,175 | 13.9% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 26 | 26 | $78,000 | $22,723 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 252 | $50,400 | $22,236 | 44.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 161 | 161 | $36,225 | $15,761 | 43.5% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 15 | 16 | $48,000 | $13,403 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 117 | 117 | $35,100 | $13,257 | 37.8% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 13 | 13 | $104,000 | $10,052 | 9.7% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 19 | 23 | $33,235 | $9,156 | 27.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 118 | 122 | $17,080 | $7,882 | 46.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 142 | 166 | $20,750 | $6,942 | 33.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 43 | 43 | $11,352 | $4,466 | 39.3% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 27 | 82 | $20,500 | $4,287 | 20.9% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 11 | 12 | $17,280 | $2,264 | 13.1% |
| 92250 | Photography of the retina | Office | 2023 | 50 | 50 | $10,000 | $1,281 | 12.8% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 61 | 70 | $5,600 | $1,176 | 21.0% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 13 | 19 | $5,643 | $696.29 | 12.3% |
| 68200 | Injection into conjunctiva | Office | 2023 | 28 | 38 | $11,780 | $614.08 | 5.2% |
About Dr. Jacob Meyer, MD
Dr. Jacob Meyer, MD is a Ophthalmology healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1588837645.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacob Meyer, MD has received a total of $5,084 in payments from pharmaceutical and medical device companies, with $365.68 received in 2024. These payments were reported across 58 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($2,500).
As a Medicare-enrolled provider, Meyer has provided services to 19,319 Medicare beneficiaries, totaling 95,569 services with total Medicare billing of $13.0M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Ophthalmology
- Location Charlottesville, VA
- Active Since 04/10/2008
- Last Updated 06/25/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1588837645
Products in Payments
- OZURDEX (Drug) $3,488
- EYLEA HD (Biological) $238.37
- EYLEA AFLIBERCEPT INJECTION (Biological) $213.13
- Izervay (Drug) $175.51
- ILUVIEN (Drug) $174.77
- Iluvien (Drug) $144.68
- Vabysmo (Drug) $136.36
- EYLEA (Biological) $132.15
- VRAYLAR (Drug) $110.43
- BEXSERO (Biological) $63.72
- Lucentis (Biological) $48.15
- VABYSMO (Drug) $33.63
- IHEEZO (Drug) $32.14
- ZOOM Wireless Transmitter (Device) $29.16
- BROLUCIZUMAB (Drug) $27.22
- YUTIQ (Drug) $20.05
- ForeseeHome (Device) $16.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Charlottesville
Dr. Marc Odrich, M.d, M.D
Ophthalmology — Payments: $1.3M
Jayakrishna Ambati, Md, MD
Ophthalmology — Payments: $355,360
Michael Grant, M.d, M.D
Ophthalmology — Payments: $209,506
Maria Kirzhner, M.d, M.D
Ophthalmology — Payments: $58,735
Peter Netland, Md, MD
Ophthalmology — Payments: $35,884
Dr. Mohit Nanda, Md, MD
Ophthalmology — Payments: $31,152